Silencing cMyc Translation as a Therapeutic Strategy Through Targeting PI3K Delta and CK1 Epsilon in Hematological Malignancies.

Drug Category : Array
Conference Category : Array
Lead Author : Deng C, et al.
Published Date : 04/12/2016
Download Link : https://www.tgtherapeutics.com/wp-content/uploads/2019/03/ASH%202016%20Deng%20Final.pdf
Download Text : Download
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top